Zusammenfassung
Wie bei Dermatika erscheinen auch bei Kosmetika Studien zur Überprüfung der Wirksamkeit erforderlich, die den Ansprüchen der evidenzbasierten Medizin (EBM) genügen. Obwohl das Konzept einer evidenzbasierten Kosmetik (EBK) bislang nur in Ansätzen entfaltet worden ist, gibt es doch bereits Präparate, die als evidenzbasiert gelten können. Daten aus verschiedenen Studien werden dargestellt, welche den Anspruch erheben, die Wirksamkeit kosmetischer Zubereitungen zum Management einiger ausgewählter Hautprobleme wie Cellulite, Striae distensae sowie Acne vulgaris nach EBM-Kriterien zu dokumentieren. Weitere wissenschaftlich fundierte Studien sind notwendig, um alle wichtigen Einsatzgebiete von Wirkkosmetika abzudecken. In der Zukunft gilt es zudem, weitergehende Fragen zu beantworten wie die nach der Nachhaltigkeit erzielter Wirkungen.
Abstract
As with dermatics, studies that verify the efficacy of cosmetics and meet the criteria of evidence-based medicine (EBM) appear to be necessary. Although the concept of evidence-based cosmetics (EBC) is still in its initial stages, some preparations are already available which can be classified as evidence-based. In this publication we present data from different studies documenting the efficacy of cosmetic preparations for the management of several skin disorders such as cellulite, stretch marks and acne vulgaris in accordance with EBM criteria. Further scientific studies are necessary to examine all important application areas of these cosmetics. Furthermore, the sustainability of the obtained effects will also need to be substantiated.
Schlüsselwörter
Cellulite - evidenzbasierte Kosmetik - Schwangerschaftsstreifen - Acne vulgaris
Key words
cellulite - evidence‐based cosmetics - stretch marks - acne vulgaris
Literatur
1
Sackett D L, Rosenberg W MC, Gray J AM, Haynes R B, Richardson W S.
Evidence based medicine: what it is and what it isn't.
Br Med J.
1996;
312
71-72
2
Eccles M, Freemantle N, Mason J.
North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care.
Br Med J.
1998;
316
1232-1235
3
Hyland M E.
Methodology for the scientific evaluation of complementary and alternative medicine.
Complement Ther Med.
2003;
11
146-153
4
Serup J.
Efficacy testing of cosmetic products. A proposal to the European Community by the Danish Environmental Protection Agency, Ministry of Environment and Energy.
Skin Res Technol.
2001;
7
141-151
5 Korting H C. Evidenzbasierte Dermatika und Kosmetika. Plewig G, Kaudewitz P, Sander CA Fortschritte der praktischen Dermatologie und Venerologie. Band 19. Berlin; Springer 2004: 548-554
6 Braun-Falco O, Gloor M, Korting H C. Nutzen und Risiko von Kosmetika. Berlin, Heidelberg; Springer 2000: 179-184
7 Braun-Falco O, Plewig G, Wolff H H, Burgdorf W, Landthaler M. Dermatologie und Venerologie. Berlin; Springer 2005: 665-666
8
Pavicic T, Borelli C, Korting H C.
Cellulite – das größte Hautproblem des Gesunden? Eine Annäherung.
J Dtsch Dermatol Ges.
2006;
4
861-870
9
Lesser T, Ritvo E, Moy L S.
Modification of subcutaneus adipose tissue by a methylxanthine formulation; a double-blind controlled study.
Dermatol Surg.
1999;
25
455-462
10
Kligman A M, Pagnoni A, Stoudermayer T.
Topical retinol improves cellulite.
J Dermatol Treatm.
1999;
10
119-125
11
Bertin C, Zunino H, Pittet J C, Beau P, Pineau P, Massonneau M, Rober J.
A double-blind evaluation of the activity of an anti-cellulite product containing retinol, caffeine, and ruscogenine by a combination of several non-invasive methods.
J Cosmet Sci.
2001;
52
199-210
12
Piérard-Franchimont C, Piérard G E, Henry F, Vroome V, Cauwenbergh G.
A randomized, placebo-controlled trial of topical retinol in the treatment of cellulite.
Am J Clin Dermatol.
2000;
1
369-374
13
Rao J, Paabo K E, Goldman M P.
A double-blind randomized trial testing the tolerability and efficacy of a novel topical agent with and without occlusion for the treatment of cellulite: a study and review of the literature.
J Drugs Dermatol.
2004;
3
417-425
14
Avram M M.
Cellulite: a review of its physiology and treatment.
J Cosmet Laser Ther.
2004;
6
181-185
15
Mallol J, Bleda M A, Costa D, Noval A, Sola M.
Prophylaxis of striae gravidarum with a topical formulation. A double-blind trial.
Int J Cosmet Sci.
1991;
13
51-57
16
Marquart F X, Bellon G, Gillery P, Wegrowski Y, Borel J P.
Stimulation of collagen synthesis in fibroblast cultures by a triterpene extracted from Centella asiatica.
Int Rev Connect Tissue Res.
1990;
24
107-120
17
Tholon L, Neliat G, Chesne C, Saboureau D, Derrier B, Branka J E.
An in vitro, ex vivo and in vivo demonstration of the lipolytic effect of slimming liposomes: An unexpected alpha 2-adrenergic antagonism.
J Cosmet Sci.
2002;
53
209-218
18
Young G L, Jewell D.
Creams for preventing stretch marks in pregnancy.
Cochrane Database Syst Rev.
2002;
CD000066
19
Korting H C, Ponce-Pöschl E, Klövekorn W, Schmötzer G, Arens-Corell J, Braun-Falco O.
The influence of the regular use of an acidic syndet bar on pre-acne.
Infection.
1995;
23
25-29
20 Plewig G, Kligman A M. Akne und Rosazea. Berlin; Springer 1994: 36
Dr. Tatjana Pavicic
Klinik und Poliklinik für Dermatologie und Allergologie – Klinikum der LMU
Frauenlobstraße 9 – 11
80337 München
Email: tatjana.pavicic@med.uni-muenchen.de